ronald omolo ouma
ID: UNCST-2023-R007754
|
Dementia Detection from a Generated Runyankole-Rukiga Speech-Data set with Speech Analysis and Machine Learning Techniques
REFNo: HS5749ES
1. To generate a dementia speech dataset for Runyankole-Rukiga in southwestern Uganda
2. To build and pilot test a speech-based machine learning algorithm that distinguishes a person with dementia from one without dementia among Runyankole-Rukiga speakers within Southwestern Uganda
|
Uganda |
2025-04-11 16:25:55 |
2028-04-11 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Arinaitwe Juliet
ID: UNCST-2024-R016009
|
PERCEPTION OF TEACHERS ON ADMINISTRATIVE SKILLS OF HEADTEACHERS AND SCHOOL CLIMATE IN SECONDARY SCHOOLS
REFNo: SS3754ES
To find out the relationship between the administrative skills of headteachers and school climate as perceived by secondary school teachers.
To find out the difference in the perceptions of secondary school teachers on the administrative skills of headteachers and school climate with regard to; Age, Gender, Educational qualifications, Teaching experience, Years spent in the same school, Type of school, and Locality of the school.
To determine which specific administrative skill of the headteacher has a stronger influence on the school climate as perceived by secondary school teachers.
To find out the impact of the administrative skills of headteachers on teachers’ professional development and work environment.
|
Uganda |
2025-04-11 16:24:58 |
2028-04-11 |
Social Science and Humanities |
Non-Clinical Trial |
Degree Award |
|
ANNA TURUMANYA KALUMUNA
ID: UNCST-2023-R006534
|
ACCEPTABILITY OF AMBULATORY SURGERY WITH AN INNOVATIVE RECOVERY AT
HOME PROGRAM, AND ITS ASSOCIATED FACTORS AMONG SELECTED HEALTH SYSTEM
STAKEHOLDERS IN UGANDA
REFNo: HS5528ES
1. To determine the level of acceptability of ambulatory surgery with an innovative at
recovery at home program among selected health system stakeholders in Uganda
2. To analyze the factors associated with the acceptability of ambulatory surgery with an
innovative at recovery at home program, among selected health system stakeholders in
Uganda
3. To establish the intrapersonal factors associated with the acceptability of ambulatory
surgery with an innovative at recovery at home program, among selected health system
stakeholders in Uganda
4. To assess the institutional factors associated with the acceptability of ambulatory surgery
with an innovative at recovery at home program, among selected health system
stakeholders in Uganda
|
Uganda |
2025-04-11 16:23:23 |
2028-04-11 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
John Mark Kazibwe
ID: UNCST-2024-R002834
|
PREVALENCE AND FACTORS ASSOCIATED WITH POSTPARTUM USE OF LONG-ACTING REVERSIBLE CONTRACEPTIVES AMONG WOMEN 15- 45 YEARS, IN BUTAMBALA DISTRICT, SOUTH CENTRAL UGANDA
REFNo: HS5563ES
General objectives.
To determine the prevalence and factors associated with post-partum use of long-acting reversible contraception within 12 months after birth, among women aged 15-45 years in Butambala district.
Specific objectives.
1. To ascertain the prevalence of postpartum use of long-acting reversible contraception within the first 12 months after childbirth among women aged 15-45 years in Butambala district.
2. To determine socio-demographic factors associated with postpartum use of long-acting reversible contraception within the first 12 months after childbirth among women aged 15-45 years in Butambala district.
3. To determine obstetric factors associated with postpartum use of long-acting reversible contraception within the first 12 months after childbirth among women aged 15-45 years in Butambala district.
|
Uganda |
2025-04-11 16:22:09 |
2028-04-11 |
Medical and Health Sciences |
Non-Clinical Trial |
Degree Award |
|
Flavia Matovu Kiweewa
ID: UNCST-2021-R013337
|
An Open-label, Single-arm Study to Provide Continued Access to Study Drug to Participants Who Have Completed Pediatric Clinical Studies Involving Gilead HIV Treatments.
REFNo: HS5804ES
The primary objective of this trial is to provide continued access to the study medication received in the parent protocol or switch to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF; coformulated; Biktarvy®) for participants who completed a Gilead parent study evaluating medications for HIV treatment.
|
Uganda |
2025-04-11 16:20:58 |
2028-04-11 |
Medical and Health Sciences |
Clinical Trial |
Non-degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|